| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.973 | 0.002 | 0.973 | Aldehyde oxidase inhibitor | 0.667 0.011 CID_154699661 | ||
| 0.877 | 0.004 | 0.877 | 12-Lipoxygenase inhibitor | 0.241 0.114 CID_154699661 | ||
| 0.854 | 0.005 | 0.854 | 15-Lipoxygenase inhibitor | 0.244 0.169 CID_154699661 | ||
| 0.837 | 0.006 | 0.837 | Caspase 9 stimulant | 0.821 0.008 CID_154699661 | ||
| 0.827 | 0.005 | 0.827 | Aryl hydrocarbon receptor agonist | 0.336 0.051 CID_154699661 | ||
| 0.725 | 0.005 | 0.725 | Lipoxygenase inhibitor | 0.224 0.119 CID_154699661 | ||
| 0.722 | 0.003 | 0.74 | Aldehyde dehydrogenase inhibitor | 0.74 0.002 CID_154699661 | CID_154699661 | |
| 0.72 | 0.002 | 0.72 | Macrophage migration inhibitory factor inhibitor | 0.148 0.016 CID_154699661 | ||
| 0.72 | 0.005 | 0.72 | Caspase 3 stimulant | 0.588 0.011 CID_154699661 | ||
| 0.728 | 0.026 | 0.757 | Apoptosis agonist | 0.757 0.022 CID_154699661 | CID_154699661 | |
| 0.705 | 0.004 | 0.705 | Hypoxia-inducible factor 1 alpha inhibitor | 0.703 0.004 CID_154699661 | ||
| 0.702 | 0.004 | 0.702 | MAO A inhibitor | 0.099 0.065 CID_154699661 | ||
| 0.699 | 0.006 | 0.796 | Antioxidant | 0.796 0.004 CID_154699661 | CID_154699661 | |
| 0.69 | 0.003 | 0.826 | Melanin inhibitor | 0.826 0.002 CID_154699661 | CID_154699661 | |
| 0.689 | 0.004 | 0.689 | MAO inhibitor | |||
| 0.669 | 0.004 | 0.669 | Breast cancer-resistant protein inhibitor | 0.176 0.017 CID_154699661 | ||
| 0.68 | 0.023 | 0.906 | Transcription factor NF kappa B inhibitor | 0.906 0.006 CID_154699661 | CID_154699661 | |
| 0.657 | 0.004 | 0.907 | Monophenol monooxygenase inhibitor | 0.907 0.002 CID_154699661 | CID_154699661 | |
| 0.651 | 0.006 | 0.72 | Free radical scavenger | 0.72 0.005 CID_154699661 | CID_154699661 | |
| 0.677 | 0.038 | 0.887 | Alpha-glucosidase inhibitor | 0.887 0.008 CID_154699661 | CID_154699661 | |
| 0.641 | 0.004 | 0.641 | NOS3 expression enhancer | 0.611 0.004 CID_154699661 | ||
| 0.611 | 0.003 | 0.611 | NADPH oxidase inhibitor | 0.578 0.004 CID_154699661 | ||
| 0.608 | 0.004 | 0.608 | MAO B inhibitor | |||
| 0.611 | 0.007 | 0.611 | Amyloid beta aggregation inhibitor | 0.423 0.022 CID_154699661 | ||
| 0.581 | 0.009 | 0.816 | Vasodilator, coronary | 0.816 0.004 CID_154699661 | CID_154699661 | |
| 0.572 | 0.005 | 0.572 | Pyruvate kinase inhibitor | 0.246 0.062 CID_154699661 | ||
| 0.558 | 0.005 | 0.558 | Peroxidase inhibitor | |||
| 0.552 | 0.016 | 0.721 | Histamine release inhibitor | 0.721 0.004 CID_154699661 | CID_154699661 | |
| 0.535 | 0.005 | 0.801 | Amylase inhibitor | 0.801 0.002 CID_154699661 | CID_154699661 | |
| 0.52 | 0.006 | 0.52 | Topoisomerase II inhibitor | 0.513 0.006 CID_154699661 | ||
| 0.497 | 0.003 | 0.497 | Histidine decarboxylase inhibitor | 0.131 0.023 CID_154699661 | ||
| 0.495 | 0.013 | 0.495 | Superoxide dismutase inhibitor | |||
| 0.486 | 0.008 | 0.486 | Tubulin antagonist | 0.157 0.055 CID_154699661 | ||
| 0.479 | 0.004 | 0.711 | Xanthine oxidase inhibitor | 0.711 0.002 CID_154699661 | CID_154699661 | |
| 0.482 | 0.018 | 0.574 | Antiamyloidogenic | 0.574 0.01 CID_154699661 | CID_154699661 | |
| 0.494 | 0.034 | 0.596 | 5 Hydroxytryptamine release inhibitor | 0.596 0.011 CID_154699661 | CID_154699661 | |
| 0.453 | 0.008 | 0.453 | Bone formation stimulant | 0.326 0.014 CID_154699661 | ||
| 0.487 | 0.044 | 0.487 | Prostaglandin dehydrogenase inhibitor | |||
| 0.448 | 0.02 | 0.579 | Nitric oxide antagonist | 0.579 0.011 CID_154699661 | CID_154699661 | |
| 0.447 | 0.02 | 0.649 | Tumour necrosis factor alpha release inhibitor | 0.649 0.005 CID_154699661 | CID_154699661 | |
| 0.445 | 0.028 | 0.586 | Apoptosis antagonist | 0.586 0.011 CID_154699661 | CID_154699661 | |
| 0.409 | 0.005 | 0.409 | Cystathionine beta-synthase inhibitor | 0.326 0.008 CID_154699661 | ||
| 0.422 | 0.024 | 0.429 | DNA damaging | 0.429 0.023 CID_154699661 | CID_154699661 | |
| 0.402 | 0.007 | 0.402 | Acetylcholinesterase inhibitor | 0.153 0.053 CID_154699661 | ||
| 0.394 | 0.004 | 0.394 | Succinate dehydrogenase inhibitor | 0.173 0.076 CID_154699661 | ||
| 0.422 | 0.036 | 0.566 | Spasmolytic | 0.566 0.016 CID_154699661 | CID_154699661 | |
| 0.389 | 0.004 | 0.791 | Beta glucuronidase inhibitor | 0.791 0.002 CID_154699661 | CID_154699661 | |
| 0.399 | 0.016 | 0.399 | P-glycoprotein inhibitor | 0.311 0.027 CID_154699661 | ||
| 0.385 | 0.003 | 0.385 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.116 0.031 CID_154699661 | ||
| 0.38 | 0.005 | 0.38 | Topoisomerase II alpha inhibitor | 0.372 0.005 CID_154699661 | ||
| 0.378 | 0.015 | 0.581 | Hepatoprotectant | 0.581 0.005 CID_154699661 | CID_154699661 | |
| 0.371 | 0.011 | 0.564 | DNA methyltransferase I inhibitor | 0.564 0.004 CID_154699661 | CID_154699661 | |
| 0.463 | 0.104 | 0.773 | Antiinflammatory | 0.773 0.019 CID_154699661 | CID_154699661 | |
| 0.365 | 0.007 | 0.365 | Alkaline phosphatase inhibitor | 0.337 0.008 CID_154699661 | ||
| 0.358 | 0.004 | 0.358 | Estrogen receptor alpha antagonist | |||
| 0.356 | 0.005 | 0.356 | Estrogen antagonist | 0.168 0.018 CID_154699661 | ||
| 0.353 | 0.003 | 0.353 | Papain-like protease (SARS coronavirus) inhibitor | 0.213 0.008 CID_154699661 | ||
| 0.351 | 0.003 | 0.351 | CF transmembrane conductance regulator agonist | 0.26 0.005 CID_154699661 | ||
| 0.352 | 0.005 | 0.352 | Estrogen receptor beta antagonist | 0.119 0.033 CID_154699661 | ||
| 0.348 | 0.002 | 0.348 | DOPA decarboxylase inhibitor | 0.136 0.03 CID_154699661 | ||
| 0.373 | 0.028 | 0.373 | Antimitotic | 0.18 0.096 CID_154699661 | ||
| 0.401 | 0.057 | 0.401 | Thioredoxin glutathione reductase inhibitor | |||
| 0.353 | 0.013 | 0.418 | Lipid peroxidase inhibitor | 0.418 0.009 CID_154699661 | CID_154699661 | |
| 0.348 | 0.009 | 0.348 | Heat shock protein 90 alpha antagonist | |||
| 0.348 | 0.01 | 0.348 | Amyloid beta precursor protein antagonist | 0.164 0.087 CID_154699661 | ||
| 0.345 | 0.014 | 0.345 | Cholinergic | |||
| 0.33 | 0.004 | 0.33 | Interleukin 5 antagonist | 0.212 0.005 CID_154699661 | ||
| 0.33 | 0.005 | 0.33 | Alcohol dehydrogenase inhibitor | 0.307 0.005 CID_154699661 | ||
| 0.341 | 0.018 | 0.546 | DNA methylase inhibitor | 0.546 0.005 CID_154699661 | CID_154699661 | |
| 0.328 | 0.007 | 0.328 | Heat shock protein 90 antagonist | 0.152 0.073 CID_154699661 | ||
| 0.33 | 0.018 | 0.33 | Mcl-1 antagonist | |||
| 0.339 | 0.029 | 0.339 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.344 | 0.035 | 0.439 | Vasodilator | 0.439 0.017 CID_154699661 | CID_154699661 | |
| 0.344 | 0.039 | 0.653 | Hypoglycemic | 0.653 0.006 CID_154699661 | CID_154699661 | |
| 0.304 | 0.005 | 0.304 | Estrogen agonist | 0.203 0.008 CID_154699661 | ||
| 0.384 | 0.084 | 0.691 | Antibacterial | 0.691 0.009 CID_154699661 | CID_154699661 | |
| 0.327 | 0.04 | 0.755 | Angiogenesis stimulant | 0.755 0.004 CID_154699661 | CID_154699661 | |
| 0.305 | 0.022 | 0.305 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.24 0.047 CID_154699661 | ||
| 0.311 | 0.029 | 0.311 | RNA-directed DNA polymerase inhibitor | 0.239 0.056 CID_154699661 | ||
| 0.398 | 0.12 | 0.398 | DNA polymerase beta inhibitor | |||
| 0.297 | 0.019 | 0.297 | Protein-tyrosine phosphatase inhibitor | 0.243 0.033 CID_154699661 | ||
| 0.357 | 0.082 | 0.357 | GABA C receptor rho-3 antagonist | |||
| 0.283 | 0.013 | 0.341 | Topoisomerase I inhibitor | 0.341 0.008 CID_154699661 | CID_154699661 | |
| 0.299 | 0.034 | 0.454 | Platelet adhesion inhibitor | 0.454 0.008 CID_154699661 | CID_154699661 | |
| 0.311 | 0.048 | 0.311 | Transcription factor STAT3 inhibitor | |||
| 0.276 | 0.016 | 0.276 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.268 | 0.01 | 0.268 | Carbonic anhydrase XV inhibitor | |||
| 0.279 | 0.024 | 0.279 | I kappa B kinase epsilon inhibitor | |||
| 0.256 | 0.004 | 0.256 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.3 | 0.048 | 0.3 | Interleukin antagonist | 0.172 0.102 CID_154699661 | ||
| 0.259 | 0.008 | 0.259 | Toll-Like receptor 2 antagonist | 0.129 0.068 CID_154699661 | ||
| 0.265 | 0.014 | 0.265 | 5-Lipoxygenase inhibitor | |||
| 0.256 | 0.011 | 0.256 | Neurotrophic factor | 0.187 0.034 CID_154699661 | ||
| 0.299 | 0.059 | 0.299 | Insulysin inhibitor | |||
| 0.272 | 0.033 | 0.272 | Dual specificity phosphatase inhibitor | |||
| 0.258 | 0.023 | 0.258 | Phospholipase C inhibitor | 0.188 0.053 CID_154699661 | ||
| 0.241 | 0.007 | 0.362 | Photosensitizer | 0.362 0.003 CID_154699661 | CID_154699661 | |
| 0.238 | 0.005 | 0.238 | Multidrug resistance-associated protein 1 inhibitor | 0.214 0.008 CID_154699661 | ||
| 0.247 | 0.015 | 0.247 | Butyrylcholinesterase inhibitor | |||
| 0.239 | 0.01 | 0.297 | Carbonic anhydrase XIII inhibitor | 0.297 0.006 CID_154699661 | CID_154699661 | |
| 0.362 | 0.133 | 0.362 | DNA directed DNA polymerase inhibitor | |||
| 0.29 | 0.062 | 0.29 | Transcription factor STAT inhibitor | |||
| 0.232 | 0.004 | 0.232 | Xanthine dehydrogenase inhibitor | 0.111 0.013 CID_154699661 | ||
| 0.232 | 0.007 | 0.232 | MAP kinase kinase 4 inhibitor | 0.156 0.051 CID_154699661 | ||
| 0.241 | 0.018 | 0.241 | Protein-tyrosine phosphatase 1B inhibitor | 0.222 0.023 CID_154699661 | ||
| 0.233 | 0.011 | 0.233 | Carbonic anhydrase III inhibitor | 0.131 0.037 CID_154699661 | ||
| 0.27 | 0.051 | 0.27 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.351 | 0.135 | 0.351 | MAP kinase 1 inhibitor | |||
| 0.23 | 0.015 | 0.617 | Expectorant | 0.617 0.003 CID_154699661 | CID_154699661 | |
| 0.23 | 0.017 | 0.23 | Mannose-6-phosphate isomerase inhibitor | 0.214 0.024 CID_154699661 | ||
| 0.247 | 0.035 | 0.247 | Nitric-oxide synthase stimulant | 0.243 0.038 CID_154699661 | ||
| 0.226 | 0.02 | 0.226 | Chelator | 0.109 0.066 CID_154699661 | ||
| 0.222 | 0.017 | 0.222 | Antibacterial (Helicobacter pylori) | 0.138 0.058 CID_154699661 | ||
| 0.216 | 0.012 | 0.216 | Telomerase inhibitor | |||
| 0.287 | 0.084 | 0.287 | Streptokinase A inhibitor | |||
| 0.257 | 0.055 | 0.257 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.209 | 0.009 | 0.209 | HIV-1 integrase (3'-Processing) inhibitor | 0.099 0.026 CID_154699661 | ||
| 0.209 | 0.01 | 0.209 | Protein kinase C zeta inhibitor | |||
| 0.208 | 0.012 | 0.208 | Carbonic anhydrase VI inhibitor | 0.094 0.043 CID_154699661 | ||
| 0.204 | 0.008 | 0.434 | DNA repair enzyme inhibitor | 0.434 0.003 CID_154699661 | CID_154699661 | |
| 0.257 | 0.065 | 0.257 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.225 | 0.033 | 0.392 | Protein kinase stimulant | 0.392 0.009 CID_154699661 | CID_154699661 | |
| 0.197 | 0.006 | 0.197 | Alpha tubulin antagonist | |||
| 0.196 | 0.009 | 0.196 | Aromatase inhibitor | |||
| 0.195 | 0.008 | 0.195 | Beta tubulin antagonist | |||
| 0.234 | 0.048 | 0.255 | Neurotrophic factor enhancer | 0.255 0.036 CID_154699661 | CID_154699661 | |
| 0.201 | 0.019 | 0.201 | Interleukin 1b antagonist | 0.151 0.039 CID_154699661 | ||
| 0.202 | 0.022 | 0.202 | Interleukin 4 antagonist | 0.171 0.034 CID_154699661 | ||
| 0.188 | 0.012 | 0.188 | Urease inhibitor | |||
| 0.178 | 0.005 | 0.178 | Estrogen receptor beta agonist | 0.118 0.009 CID_154699661 | ||
| 0.185 | 0.013 | 0.185 | Creatine kinase inhibitor | |||
| 0.217 | 0.047 | 0.217 | Histone acetyltransferase inhibitor | |||
| 0.207 | 0.038 | 0.39 | Interferon gamma antagonist | 0.39 0.011 CID_154699661 | CID_154699661 | |
| 0.218 | 0.052 | 0.218 | Dual specificity phosphatase 3 inhibitor | |||
| 0.199 | 0.036 | 0.351 | Hexokinase inhibitor | 0.351 0.006 CID_154699661 | CID_154699661 | |
| 0.219 | 0.058 | 0.507 | Non-steroidal antiinflammatory agent | 0.507 0.006 CID_154699661 | CID_154699661 | |
| 0.238 | 0.078 | 0.238 | Dyrk kinase inhibitor | |||
| 0.233 | 0.073 | 0.43 | Cyclic AMP phosphodiesterase inhibitor | 0.43 0.013 CID_154699661 | CID_154699661 | |
| 0.271 | 0.11 | 0.271 | Thyroid hormone antagonist | |||
| 0.194 | 0.036 | 0.194 | Interleukin 1 antagonist | |||
| 0.167 | 0.009 | 0.174 | Aldose reductase inhibitor | 0.174 0.009 CID_154699661 | CID_154699661 | |
| 0.159 | 0.004 | 0.159 | Fatty acid synthase inhibitor | 0.08 0.019 CID_154699661 | ||
| 0.171 | 0.017 | 0.171 | Heat shock protein 70 antagonist | 0.171 0.017 CID_154699661 | ||
| 0.189 | 0.035 | 0.189 | GABA C receptor rho-2 antagonist | |||
| 0.241 | 0.093 | 0.241 | 5 Hydroxytryptamine release stimulant | 0.19 0.13 CID_154699661 | ||
| 0.159 | 0.012 | 0.159 | HIV-1 integrase (Strand Transfer) inhibitor | 0.083 0.029 CID_154699661 | ||
| 0.173 | 0.035 | 0.173 | Cholesterol synthesis inhibitor | 0.112 0.073 CID_154699661 | ||
| 0.156 | 0.018 | 0.156 | Electron transport complex I inhibitor | 0.108 0.066 CID_154699661 | ||
| 0.257 | 0.12 | 0.257 | Sodium/bile acid cotransporter inhibitor | 0.198 0.191 CID_154699661 | ||
| 0.131 | 0.003 | 0.131 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.251 | 0.124 | 0.457 | Cholesterol antagonist | 0.457 0.039 CID_154699661 | CID_154699661 | |
| 0.132 | 0.006 | 0.132 | Estrogen receptor alpha agonist | 0.044 0.019 CID_154699661 | ||
| 0.149 | 0.023 | 0.174 | Uric acid excretion stimulant | 0.174 0.017 CID_154699661 | CID_154699661 | |
| 0.287 | 0.162 | 0.287 | Transcription factor inhibitor | |||
| 0.186 | 0.06 | 0.186 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.153 | 0.03 | 0.153 | Bronchodilator | 0.117 0.047 CID_154699661 | ||
| 0.133 | 0.01 | 0.133 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.178 | 0.056 | 0.178 | Arachidonic acid antagonist | |||
| 0.178 | 0.057 | 0.178 | Death-associated protein kinase 2 inhibitor | |||
| 0.136 | 0.017 | 0.136 | Keratolytic | |||
| 0.13 | 0.016 | 0.13 | Myeloperoxidase inhibitor | |||
| 0.135 | 0.021 | 0.135 | CYP2A6 inhibitor | |||
| 0.163 | 0.05 | 0.163 | Cyclooxygenase 1 inhibitor | 0.115 0.085 CID_154699661 | ||
| 0.254 | 0.142 | 0.254 | Calcium channel activator | |||
| 0.179 | 0.068 | 0.179 | Tumour necrosis factor antagonist | |||
| 0.116 | 0.008 | 0.116 | Carbonic anhydrase VII inhibitor | 0.06 0.019 CID_154699661 | ||
| 0.149 | 0.042 | 0.155 | Beta amyloid protein antagonist | 0.155 0.037 CID_154699661 | CID_154699661 | |
| 0.109 | 0.003 | 0.109 | Estrogen-related receptor beta antagonist | 0.049 0.005 CID_154699661 | ||
| 0.143 | 0.037 | 0.163 | Mucolytic | 0.163 0.026 CID_154699661 | CID_154699661 | |
| 0.279 | 0.175 | 0.279 | Calcium channel L-type activator | |||
| 0.116 | 0.013 | 0.135 | Phosphodiesterase VI inhibitor | 0.135 0.009 CID_154699661 | CID_154699661 | |
| 0.167 | 0.065 | 0.167 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.109 | 0.007 | 0.109 | Glutamate (mGluR7) antagonist | |||
| 0.103 | 0.005 | 0.103 | Transcription factor RelA inhibitor | |||
| 0.161 | 0.064 | 0.284 | Insulin secretagoues | 0.284 0.014 CID_154699661 | CID_154699661 | |
| 0.116 | 0.019 | 0.116 | Lipase inhibitor | 0.076 0.047 CID_154699661 | ||
| 0.109 | 0.013 | 0.109 | CDC25B inhibitor | |||
| 0.21 | 0.119 | 0.21 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.11 | 0.02 | 0.11 | D-Ala-D-Ala ligase inhibitor | |||
| 0.109 | 0.02 | 0.109 | HIV-1 integrase inhibitor | |||
| 0.139 | 0.051 | 0.139 | Vanilloid 1 agonist | 0.121 0.086 CID_154699661 | ||
| 0.223 | 0.136 | 0.223 | Thyroid hormone beta antagonist | |||
| 0.139 | 0.053 | 0.139 | Proteasome inhibitor | |||
| 0.148 | 0.066 | 0.148 | Adenylate cyclase stimulant | |||
| 0.151 | 0.069 | 0.151 | Cyclooxygenase inhibitor | 0.115 0.105 CID_154699661 | ||
| 0.091 | 0.01 | 0.091 | Potassium channel Kv1.3 blocker | |||
| 0.09 | 0.01 | 0.09 | CD45 antagonist | |||
| 0.124 | 0.045 | 0.343 | AMP-activated protein kinase stimulant | 0.343 0.004 CID_154699661 | CID_154699661 | |
| 0.115 | 0.04 | 0.258 | Antineoplastic antibiotic | 0.258 0.013 CID_154699661 | CID_154699661 | |
| 0.081 | 0.006 | 0.081 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.111 | 0.038 | 0.111 | ABCA1 expression enhancer | |||
| 0.126 | 0.054 | 0.126 | Interleukin 8 antagonist | |||
| 0.117 | 0.047 | 0.171 | Toll-Like receptor 4 antagonist | 0.171 0.012 CID_154699661 | CID_154699661 | |
| 0.097 | 0.028 | 0.097 | Leukotriene synthesis inhibitor | |||
| 0.077 | 0.009 | 0.077 | DNA-dependent protein kinase inhibitor | |||
| 0.096 | 0.03 | 0.096 | CDC25A inhibitor | |||
| 0.087 | 0.021 | 0.112 | Neuraminidase inhibitor | 0.112 0.012 CID_154699661 | CID_154699661 | |
| 0.074 | 0.009 | 0.074 | Estrogen-related receptor alpha antagonist | 0.038 0.018 CID_154699661 | ||
| 0.171 | 0.106 | 0.171 | Insulin sensitizer | |||
| 0.13 | 0.066 | 0.277 | Cyclooxygenase 3 inhibitor | 0.277 0.007 CID_154699661 | CID_154699661 | |
| 0.219 | 0.155 | 0.22 | Vasodilator, peripheral | 0.22 0.154 CID_154699661 | CID_154699661 | |
| 0.105 | 0.043 | 0.132 | Thioredoxin inhibitor | 0.132 0.024 CID_154699661 | CID_154699661 | |
| 0.124 | 0.064 | 0.25 | Alkylator | 0.25 0.017 CID_154699661 | CID_154699661 | |
| 0.118 | 0.059 | 0.178 | DNA intercalator | 0.178 0.033 CID_154699661 | CID_154699661 | |
| 0.107 | 0.05 | 0.107 | Potassium channel (Ca-activated) activator | |||
| 0.078 | 0.022 | 0.078 | Heat shock protein 90 beta antagonist | |||
| 0.119 | 0.063 | 0.119 | Protein kinase (CK2) alpha inhibitor | |||
| 0.093 | 0.037 | 0.093 | Thioredoxin reductase inhibitor | |||
| 0.09 | 0.035 | 0.09 | GABA aminotransferase inhibitor | 0.075 0.053 CID_154699661 | ||
| 0.172 | 0.119 | 0.172 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.21 | 0.158 | 0.261 | Angiogenesis inhibitor | 0.261 0.115 CID_154699661 | CID_154699661 | |
| 0.077 | 0.026 | 0.077 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.041 CID_154699661 | ||
| 0.137 | 0.087 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.132 0.107 CID_154699661 | ||
| 0.067 | 0.018 | 0.067 | Topoisomerase II beta inhibitor | 0.048 0.037 CID_154699661 | ||
| 0.107 | 0.061 | 0.235 | Mediator release inhibitor | 0.235 0.011 CID_154699661 | CID_154699661 | |
| 0.083 | 0.038 | 0.083 | Dopamine D2 antagonist | |||
| 0.065 | 0.019 | 0.107 | Glucose-6-phosphate translocase inhibitor | 0.107 0.005 CID_154699661 | CID_154699661 | |
| 0.052 | 0.008 | 0.052 | Catechol O-methyltransferase inhibitor | |||
| 0.056 | 0.014 | 0.056 | Dopamine D5 agonist | |||
| 0.127 | 0.085 | 0.154 | CC chemokine 6 receptor antagonist | 0.154 0.018 CID_154699661 | CID_154699661 | |
| 0.085 | 0.046 | 0.113 | Na+ K+ transporting ATPase inhibitor | 0.113 0.02 CID_154699661 | CID_154699661 | |
| 0.073 | 0.034 | 0.073 | Aryl hydrocarbon receptor antagonist | |||
| 0.117 | 0.078 | 0.117 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.07 | 0.034 | 0.07 | Protease activated receptor antagonist | |||
| 0.076 | 0.04 | 0.076 | Carbonic anhydrase VA inhibitor | |||
| 0.066 | 0.031 | 0.066 | Alcohol oxidase inhibitor | |||
| 0.173 | 0.137 | 0.463 | Immunostimulant | 0.463 0.034 CID_154699661 | CID_154699661 | |
| 0.057 | 0.022 | 0.064 | Factor III inhibitor | 0.064 0.014 CID_154699661 | CID_154699661 | |
| 0.081 | 0.047 | 0.081 | Dopamine antagonist | |||
| 0.12 | 0.086 | 0.12 | Toll-Like receptor 9 antagonist | |||
| 0.07 | 0.035 | 0.11 | Neuraminidase (influenza) inhibitor | 0.11 0.014 CID_154699661 | CID_154699661 | |
| 0.074 | 0.04 | 0.074 | Potassium channel large-conductance Ca-activated activator | |||
| 0.063 | 0.03 | 0.063 | Ryanodine receptor antagonist | |||
| 0.143 | 0.113 | 0.252 | ATPase inhibitor | 0.252 0.013 CID_154699661 | CID_154699661 | |
| 0.145 | 0.115 | 0.145 | Neurotensin receptor agonist | |||
| 0.056 | 0.027 | 0.091 | Carbonic anhydrase XIV inhibitor | 0.091 0.013 CID_154699661 | CID_154699661 | |
| 0.084 | 0.055 | 0.084 | Estrogen-related receptor beta agonist | |||
| 0.075 | 0.049 | 0.075 | Glutamate decarboxylase inhibitor | |||
| 0.069 | 0.043 | 0.069 | Carbonic anhydrase V inhibitor | |||
| 0.059 | 0.033 | 0.114 | Carbonic anhydrase XII inhibitor | 0.114 0.017 CID_154699661 | CID_154699661 | |
| 0.074 | 0.05 | 0.112 | Histone deacetylase SIRT1 stimulant | 0.112 0.021 CID_154699661 | CID_154699661 | |
| 0.074 | 0.05 | 0.112 | Histone deacetylase stimulant | 0.112 0.021 CID_154699661 | CID_154699661 | |
| 0.032 | 0.008 | 0.032 | Dopamine D1 agonist | 0.028 0.01 CID_154699661 | ||
| 0.083 | 0.059 | 0.083 | Phosphodiesterase IV inhibitor | |||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | |||
| 0.055 | 0.031 | 0.055 | Vanilloid 2 antagonist | |||
| 0.084 | 0.061 | 0.084 | Androgen antagonist | |||
| 0.039 | 0.016 | 0.039 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.075 | 0.053 | 0.075 | GABA B receptor agonist | |||
| 0.094 | 0.072 | 0.094 | Anabolic | |||
| 0.089 | 0.068 | 0.089 | Prolactin inhibitor | |||
| 0.091 | 0.071 | 0.091 | Sphingomyelinase inhibitor | 0.084 0.081 CID_154699661 | ||
| 0.111 | 0.091 | 0.111 | Cyclooxygenase 2 inhibitor | |||
| 0.083 | 0.063 | 0.083 | Vanilloid agonist | |||
| 0.064 | 0.045 | 0.064 | Dopamine D1 antagonist | |||
| 0.037 | 0.018 | 0.037 | Melatonin 2 agonist | |||
| 0.055 | 0.036 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.057 | 0.038 | 0.057 | Carbonic anhydrase VB inhibitor | |||
| 0.039 | 0.023 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.027 | 0.012 | 0.027 | Estrone sulfatase inhibitor | |||
| 0.14 | 0.125 | 0.141 | Psychostimulant | 0.141 0.125 CID_154699661 | CID_154699661 | |
| 0.048 | 0.033 | 0.048 | Cholesterol esterase inhibitor | |||
| 0.1 | 0.087 | 0.1 | TRPA1 agonist | |||
| 0.099 | 0.087 | 0.126 | DNA polymerase I inhibitor | 0.126 0.064 CID_154699661 | CID_154699661 | |
| 0.129 | 0.118 | 0.129 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.062 | 0.051 | 0.062 | Dopamine agonist | |||
| 0.1 | 0.091 | 0.117 | Microtubule formation inhibitor | 0.117 0.064 CID_154699661 | CID_154699661 | |
| 0.027 | 0.018 | 0.113 | Sodium/glucose cotransporter 2 inhibitor | 0.113 0.002 CID_154699661 | CID_154699661 | |
| 0.051 | 0.043 | 0.067 | Leukotriene B4 antagonist | 0.067 0.022 CID_154699661 | CID_154699661 | |
| 0.088 | 0.081 | 0.129 | Phosphodiesterase 6D inhibitor | 0.129 0.018 CID_154699661 | CID_154699661 | |
| 0.066 | 0.059 | 0.066 | Phosphodiesterase 4D inhibitor | |||
| 0.088 | 0.082 | 0.088 | GABA C receptor rho-1 antagonist | |||
| 0.057 | 0.05 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.084 | 0.079 | 0.084 | Protein kinase (CK2) inhibitor | |||
| 0.121 | 0.116 | 0.121 | Phospholipase A2 inhibitor | |||
| 0.018 | 0.015 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.164 | 0.16 | 0.368 | Peptidyltransferase inhibitor | 0.368 0.01 CID_154699661 | CID_154699661 | |
| 0.037 | 0.035 | 0.037 | Dopamine D5 antagonist | |||
| 0.053 | 0.052 | 0.053 | Androgen agonist | |||
| 0.116 | 0.115 | 0.325 | Thrombolytic | 0.325 0.02 CID_154699661 | CID_154699661 | |
| 0.021 | 0.02 | 0.067 | Protein 30S ribosomal subunit inhibitor | 0.067 0.005 CID_154699661 | CID_154699661 | |
| 0.023 | 0.024 | 0.095 | Sodium/glucose cotransporter inhibitor | 0.095 0.003 CID_154699661 | CID_154699661 | |
| 0.017 | 0.018 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.003 CID_154699661 | CID_154699661 | |
| 0.197 | 0.2 | 0.471 | Immunosuppressant | 0.471 0.041 CID_154699661 | CID_154699661 | |
| 0.053 | 0.064 | 0.08 | Nitric oxide donor | 0.08 0.022 CID_154699661 | CID_154699661 | |
| 0.073 | 0.092 | 0.125 | NADH dehydrogenase inhibitor | 0.125 0.026 CID_154699661 | CID_154699661 | |
| 0.076 | 0.097 | 0.159 | UDP-glucose 4-epimerase inhibitor | 0.159 0.026 CID_154699661 | CID_154699661 | |
| 0.038 | 0.06 | 0.051 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.028 CID_154699661 | CID_154699661 | |
| 0.104 | 0.129 | 0.222 | Diuretic | 0.222 0.037 CID_154699661 | CID_154699661 | |
| 0.179 | 0.206 | 0.592 | Antithrombotic | 0.592 0.017 CID_154699661 | CID_154699661 | |
| 0.089 | 0.12 | 0.145 | Alpha-N-acetylglucosaminidase inhibitor | 0.145 0.058 CID_154699661 | CID_154699661 | |
| 0.048 | 0.085 | 0.064 | Lipocortins synthesis agonist | 0.064 0.028 CID_154699661 | CID_154699661 | |
| 0.151 | 0.201 | 0.308 | DNA synthesis inhibitor | 0.308 0.041 CID_154699661 | CID_154699661 | |
| 0.063 | 0.128 | 0.114 | ATPase (Vacuolar H+) inhibitor | 0.114 0.024 CID_154699661 | CID_154699661 | |
| 0.061 | 0.129 | 0.102 | Triose-phosphate isomerase inhibitor | 0.102 0.046 CID_154699661 | CID_154699661 | |
| 0.025 | 0.1 | 0.052 | Neuraminidase (Influenza A) inhibitor | 0.052 0.022 CID_154699661 | CID_154699661 | |
| 0.033 | 0.109 | 0.08 | Phosphofructokinase-1 inhibitor | 0.08 0.041 CID_154699661 | CID_154699661 | |
| 0.038 | 0.149 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.033 CID_154699661 | CID_154699661 | |
| 0.029 | 0.143 | 0.089 | Heparanase inhibitor | 0.089 0.005 CID_154699661 | CID_154699661 | |
| 0.093 | 0.219 | 0.162 | Interleukin 6 antagonist | 0.162 0.073 CID_154699661 | CID_154699661 | |
| 0.019 | 0.157 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 CID_154699661 | CID_154699661 | |
| 0.061 | 0.205 | 0.082 | T cell inhibitor | 0.082 0.058 CID_154699661 | CID_154699661 | |
| 0.019 | 0.164 | 0.093 | Protein 50S ribosomal subunit inhibitor | 0.093 0.015 CID_154699661 | CID_154699661 | |
| 0.171 | 0.322 | 0.695 | Cyclophilin D inhibitor | 0.695 0.015 CID_154699661 | CID_154699661 | |
| 0.083 | 0.235 | 0.279 | Hemostatic | 0.279 0.018 CID_154699661 | CID_154699661 | |
| 0.081 | 0.245 | 0.199 | Interleukin agonist | 0.199 0.121 CID_154699661 | CID_154699661 | |
| 0.019 | 0.2 | 0.051 | Alpha-mannosidase inhibitor | 0.051 0.041 CID_154699661 | CID_154699661 | |
| 0.015 | 0.2 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 CID_154699661 | CID_154699661 | |
| 0.06 | 0.277 | 0.175 | Cell wall synthesis inhibitor | 0.175 0.044 CID_154699661 | CID_154699661 | |
| 0.052 | 0.296 | 0.102 | Interleukin 12 antagonist | 0.102 0.05 CID_154699661 | CID_154699661 | |
| 0.055 | 0.33 | 0.211 | Hypolipemic | 0.211 0.087 CID_154699661 | CID_154699661 | |
| 0.013 | 0.29 | 0.304 | Selectin antagonist | 0.304 0.005 CID_154699661 | CID_154699661 | |
| 0.041 | 0.356 | 0.118 | Transcription factor NF kappa B stimulant | 0.118 0.026 CID_154699661 | CID_154699661 | |
| 0.042 | 0.405 | 0.238 | Platelet antagonist | 0.238 0.078 CID_154699661 | CID_154699661 | |
| 0.032 | 0.459 | 0.171 | Cell adhesion inhibitor | 0.171 0.035 CID_154699661 | CID_154699661 | |
| 0.078 | 0.606 | 0.351 | Interleukin 2 agonist | 0.351 0.045 CID_154699661 | CID_154699661 | |
| 0.014 | 0.542 | 0.078 | Cell adhesion molecule inhibitor | 0.078 0.056 CID_154699661 | CID_154699661 | |
| 0.025 | 0.757 | 0.255 | Immunomodulator | 0.255 0.111 CID_154699661 | CID_154699661 | |
| 0.008 | 0.743 | 0.143 | Anticoagulant | 0.143 0.086 CID_154699661 | CID_154699661 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |